Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ReExam Non-Final Action
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"I honestly believe our legal counsel will do the same with the latest prior art. I believe TPL's legal counsel WILL proove valid the 148 over the "newest" prior art."

The question is: Is the new prior art a surprise to TPL?

I always had the impression, Talbot was "well-known" to TPL, thus I relied on Moore & Co to persuade the USPTO - can they do the same with the new stuff?

AND: They only have ONE shot, as I understand the "final action" hint.

GLTY





1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply